Predictors of Echocardiographic Progression in Patients With Mild Aortic Stenosis
![]() |
Seo, Jeong-Sook
(Department of Cardiology, College of Medicine, Inje University, Pusan Paik Hospital)
Kang, Duk-Hyun (Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center) Kim, Dae-Hee (Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center) Song, Jong-Min (Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center) Song, Jae-Kwan (Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center) |
1 | Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Ryden L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994;23:1162-70. DOI ScienceOn |
2 | Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Ch-aracterization of the early lesion of 'degenerative' valvular aortic steno-sis: histological and immunohistochemical studies. Circulation 1994; 90:844-53. DOI ScienceOn |
3 | O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morph-ologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996;16:523-32. DOI ScienceOn |
4 | Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol 1999;19:1218-22. DOI ScienceOn |
5 | Cowell SJ, Newby DE, Prescott RJ, et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-97. DOI ScienceOn |
6 | Rossebo AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008; 359:1343-56. DOI ScienceOn |
7 | Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aor-tic stenosis progression observation: measuring effects of rosuvastatin (astronomer) trial. Circulation 2010;121:306-14. DOI ScienceOn |
8 | Owens DS, Otto CM. Is it time for a new paradigm in calcific aortic valve disease? JACC Cardiovasc Imaging 2009;2:928-30. DOI ScienceOn |
9 | Ngo DT, Sverdlov AL, Willoughby SR, et al. Determinants of occurr-ence of aortic sclerosis in an aging population. JACC Cardiovasc Im-aging 2009;2:919-27. DOI ScienceOn |
10 | Rosenhek R, Klaar U, Schemper M, et al. Mild and moderate aortic stenosis: natural history and risk stratification by echocardiography. Eur Heart J 2004;25:199-205. DOI ScienceOn |
11 | Kang DH, Park SJ, Rim JH, et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 2010;121:1502-9. DOI ScienceOn |
12 | Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymp-tomatic valvular aortic stenosis: clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-70. DOI ScienceOn |
13 | Schiller NB, Shah PM, Crawford M, et al. Recommendations for qu-antitation of the left ventricle by two-dimensional echocardiography: American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 1989;2:358-67. |
14 | Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8. DOI ScienceOn |
15 | Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001;104: 2205-9. DOI ScienceOn |
16 | Skjaerpe T, Hegrenaes L, Hatle L. Noninvasive estimation of valve area in patients with aortic stenosis by Doppler ultrasound and two-dimensional echocardiography. Circulation 1985;72:810-8. DOI ScienceOn |
17 | Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-7. DOI ScienceOn |
18 | Aronow WS, Ahn C, Kronzon I, Goldman ME. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol 2001;88:693-5. DOI ScienceOn |
19 | Bellamy MF, Pellikka PA, Klarich KW, Tajik AJ, Enriquez-Sarano M. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol 2002;40:1723-30. DOI ScienceOn |
20 | Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis. Circulation 2004;110:1291-5. DOI ScienceOn |
21 | Ryu DR, Park SJ, Han H, et al. Progression rate of aortic valve stenosis in Korean patients. J Cardiovasc Ultrasound 2010;18:127-33. DOI ScienceOn |
22 | Messika-Zeitoun D, Aubry MC, Detaint D, et al. Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography. Circulation 2004;110:356-62. DOI ScienceOn |
23 | Deutscher S, Rockette HE, Krishnaswami V. Diabetes and hypercholesterolemia among patients with calcific aortic stenosis. J Chronic Dis 1984;37:407-15. DOI ScienceOn |
24 | Caira FC, Stock SR, Gleason TG, et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein re-ceptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 2006;47:1707-12. DOI ScienceOn |
25 | Mohty D, Pibarot P, Després JP, et al. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol 2008;28:187-93. |
![]() |